# The Expression of F2RL1, P2RX2, P2RX3 and P2RY2 in the Esophagus of Patients with Gastroesophageal Reflux Disease and Their Relationship to Reflux Symptoms—A Pilot Study

**Authors:** Anna Mokrowiecka, Adrian Bartoszek, Adam Fabisiak, Agata Wróbel, Jakub Fichna, Agnieszka Wierzchniewska-Ławska, Damian Jacenik, Ewa Małecka-Wojciesko

PMC · DOI: 10.3390/jcm14061884 · Journal of Clinical Medicine · 2025-03-11

## TL;DR

This pilot study explores how certain receptors in the esophagus relate to symptoms in patients with gastroesophageal reflux disease.

## Contribution

The study identifies specific receptor expression patterns in GERD subtypes that may explain symptom differences.

## Key findings

- PAR2 receptor expression was higher in ERD compared to NERD and controls.
- P2X2 and P2Y2 expression was higher in NERD than in ERD and controls.
- Receptor expression correlated with dilated intracellular spaces and symptom intensity in GERD patients.

## Abstract

Background: The current treatment of gastroesophageal reflux disease (GERD) is focused on decreasing gastric acid secretion. However, there is still a group of patients that do not respond to conventional therapy. Proteinase-activated receptors and purinergic receptors have been implicated in inflammation, visceral hyperalgesia and esophageal hypersensitivity. The aim of this study was to evaluate the esophageal expression of PAR2 (F2RL1) and P2RX2, P2RX3 and P2RY2 in GERD patients. Methods: A total of 53 patients with GERD and 9 healthy controls were enrolled in this study. The expression of the studied receptors was quantified using real-time PCR on esophageal biopsies from the patients with GERD and healthy controls. The correlation between the dilated intracellular spaces (DIS) score and patients’ quality of life was investigated. Results: PAR2 receptor expression was higher in ERD compared to NERD and controls (326.10 ± 112.30 vs. 266.90 ± 84.76 vs. 77.60 ± 28.50; NS). P2X2 exhibited the highest expression in NERD compared to ERD and controls (302.20 ± 82.94 vs. 40.18 ± 17.78 vs. 26.81 ± 10.27), similarly to P2Y2, which expression was higher in NERD than in ERD and controls (7321.00 ± 1651.00 vs. 5306.0 ± 1738.00 vs. 3476.00 ± 508.0). Conclusions: We found that the expression of F2RL1, P2RX2 and P2RY2 is positively correlated to the DIS score in GERD patients. Higher PAR2, P2X2 and P2Y2 expression could mediate the sensitization of the esophagus and may be associated with the higher intensity of symptoms perceived by NERD patients.

## Linked entities

- **Genes:** F2RL1 (F2R like trypsin receptor 1) [NCBI Gene 2150], P2RX2 (purinergic receptor P2X 2) [NCBI Gene 22953], P2RX3 (purinergic receptor P2X 3) [NCBI Gene 5024], P2RY2 (purinergic receptor P2Y2) [NCBI Gene 5029]
- **Proteins:** F2RL1 (F2R like trypsin receptor 1), P2RX2 (purinergic receptor P2X 2), P2RY2 (purinergic receptor P2Y2)
- **Diseases:** gastroesophageal reflux disease (MONDO:0007186), GERD (MONDO:0007186)

## Full-text entities

- **Genes:** P2RX2 (purinergic receptor P2X 2) [NCBI Gene 22953] {aka DFNA41, P2X2}, P2RX3 (purinergic receptor P2X 3) [NCBI Gene 5024] {aka P2X3}, P2RY2 (purinergic receptor P2Y2) [NCBI Gene 5029] {aka HP2U, P2RU1, P2U, P2U1, P2UR, P2Y2}, F2RL1 (F2R like trypsin receptor 1) [NCBI Gene 2150] {aka GPR11, PAR2}
- **Diseases:** inflammation (MESH:D007249), esophageal hypersensitivity (MESH:D004935), GERD (MESH:D005764), visceral hyperalgesia (MESH:D006930)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11942676/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11942676/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC11942676/full.md

---
Source: https://tomesphere.com/paper/PMC11942676